Author： Crow Scott Brown Eric
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.3, 2003-03, pp. : 491-499
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The eating disorders anorexia nervosa, bulimia nervosa and binge eating disorder are common, significant public health problems which are treated with nutritional, psychotherapeutic and pharmacological interventions. A number of drugs (mostly antidepressant drugs) are currently used in their treatment to some benefit, but there is substantial room for improvement. A wide variety of compounds are listed as under investigation for the treatment of eating disorders. They have a diverse variety of mechanisms of action, reflecting the complex nature of the control of food intake. While none of these compounds are close to release at present, the diversity of mechanisms under study lend some optimism that more effective approaches will be identified.
Related content
Investigational drugs for eating disorders
By Crow S.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. :
Access to resources
Recommend
By Camins Antoni Sureda Francesc Xavier Junyent Felix Verdaguer Ester Folch Jaume Beas-Zarate Carlos Pallas Merce
Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. :
Investigational drugs for pruritus
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 9, 2013-09 ,pp. :